Circulating Angiogenic Factors and the Risk of Preeclampsia
Richard J. Levine, Sharon E. Maynard, Cong Qian, Kee-Hak Lim, Lucinda J. England, Kai F. Yu, Enrique F. Schisterman, Ravi Thadhani, Benjamin Sachs, Franklin H. Epstein, Baha M. Sibai, Vikas P. Sukhatme, S. Ananth Karumanchi
New England Journal of Medicine, 2004
Abstract
This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).
- Circulating Angiogenic Factors in the Pathogenesis and Prediction of Preeclampsia 2005
- Threshold of Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio for the Imminent Onset of Preeclampsia 2011
- Establishing Reference Values for Both Total Soluble Fms-Like Tyrosine Kinase 1 and Free Placental Growth Factor in Pregnant Women 2005
- Prediction of imminent preeclampsia at 35–37 weeks gestation 2019
- Preeclampsia is associated with reduced serum levels of placenta growth factor 1998
- Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia 2001
- Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia 2000
- Expression and Function of Placenta Growth Factor: Implications for Abnormal Placentation 2003
- Decreased maternal serum placenta growth factor in early second trimester and preeclampsia 2001